ARCHIVES

NCI Sends A Second Letter To Groups About Carboplatin

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

September 17, 2010

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

NCI-Approved Clinical Trials

August 25, 2006

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009